Cardiovascular Effects Induced by Reticuline in Normotensive Rats

Abstract

The cardiovascular effects of reticuline, isolated in a pure form from the stem of Ocotea duckei Vattimo, were studied in rats by using a combined in vivo and in vitro approach. In normotensive rats, reticuline (5, 10 and 20 mg/kg, i. v., randomly) injections produced an intense hypotension. This hypotensive response was attenuated after either, L-NAME (20 mg/kg, i. v.), a nitric oxide (NO) synthase inhibitor, or atropine (2 mg/kg, i. v.), a muscarinic receptor antagonist. In isolated rat aortic rings with intact endothelium, reticuline (3 × 10 ^{- 6}, 3 × 10 ^{- 5}, 3 × 10 ^{- 4}, 9 × 10 ^{- 4} and 1.5 × 10 ^{- 3} M) inhibited in a concentration-dependent manner the contractions induced by phenylephrine (1 μM), KCl (80 mM) and KCl (30 mM), [IC₅₀ = (0.4 ± 0.1, 2.4 ± 0.4 and 3 ± 0.4) × 10 ^{- 4} M, respectively). The effect of reticuline on phenylephrine-induced contractions was attenuated by removal of the vascular endothelium [IC₅₀ = (2.5 ± 0.7) × 10 ^{- 4} M]. Similar results were obtained after pretreatment of the rings with L-NAME 100 μM [IC₅₀ = (1.3 ± 0.1) × 10 ^{- 4} M], L-NAME 300 μM [IC₅₀ = (3 ± 0.3) × 10 ^{- 4} M] or atropine 1 μM [IC₅₀ = (1.2 ± 0.2) × 10 ^{- 4} M]. On the other hand, the effect of reticuline on phenylephrine-induced contractions was not affected by indomethacin 1 μM [IC₅₀ = (0.7 ± 0.3) × 10 ^{- 4} M]. Reticuline (3 × 10 ^{- 6}, 3 × 10 ^{- 5}, 3 × 10 ^{- 4}, 9 × 10 ^{- 4} and 1.5 × 10 ^{- 3} M) antagonized CaCl₂-induced contractions, and also inhibited the intracellular calcium dependent transient contractions induced by norepinephrine (1 μM), but not those induced by caffeine (20 mM). These results suggest that the hypotensive effect of reticuline is probably due to a peripheral vasodilation in consequence of: 1) muscarinic stimulation and NOS activation in the vascular endothelium, 2) voltage-dependent Ca²⁺ channel blockade and/or 3) inhibition of Ca²⁺ release from norepinephrine-sensitive intracellular stores.

Key words

Reticuline - hypotension - cardiovascular - vasodilation - Ocotea duckei - Lauraceae

References

• 1 Van Den Berg M E. Plantas medicinais na Amazônia - Contribuição ao seu conhecimento sistemático. Conselho Nacional de Desenvolvimento Científico e Tecnológico - Programa de Trópicos Unidos 1982: p 223
• 2 Martin M L, Diaz M T, Montero M J, Prieto P, Roman L S, Cortes D. Antispasmodic activity of benzylisoquinoline alkaloids analogous to papaverine.  Planta Med. 1993;  59 (suppl 1) 63-7
• 3 Morais L CSL, Barbosa-Filho J M, Almeida R N. Central depressant effects of reticuline extracted from Ocotea duckei in rats and mice.  J Ethnopharmacol. 1998;  62 (suppl 1) 57-61
• 4 Watanabe H, Ikeda M, Qatanabe K, Kikuchi T. Effects on central dopaminergic systems of D-coclaurine and D-reticuline, extracted from Magnolia salicifolia .  Planta Med. 1981;  42 213-22
• 5 Martin M L, Sagredo J A, Morais J M, Montero J, Sanchez MT San Roman L. Uterine inhibitory effect of reticuline. J Pharm.  Pharmacol. 1988;  40 801-2
• 6 Kimura I, Kimura M, Yoshizadi M, Yanada K, Kadota S, Kikuchi T. Neuromuscular blocking action of alkaloids from a Japanese crude drug ”SHIN-1” (Flos Magnoliae) in frog skeletal muscle.  Planta Med. 1983;  48 43-7
• 7 Nakaoji K, Nayeshiro H, Tanahashi T. Norreticuline and reticuline as possible new agents for hair growth acceleration.  Biol Pharm Bull. 1997;  20 (suppl 5) 586-8
• 8 Smith T L, Hutchins P M. Anesthetic effects on hemodynamics of spontaneously hypertensive and Wistar-Kyoto rats.  Am J Physiol. 1980;  238 H539-44
• 9 Altura B M, Altura B T. Differential effects of substrate on drug-induced contractions of rabbit aorta.  Am J Physiol. 1970;  219 1698-705
• 10 Sakata K, Karaki H. Effects of a novel smooth muscle relaxant, KT-362, on contraction on cytosolic Ca²⁺ level in the rat aorta.  Br J Pharmacol. 1991;  102 174-8
• 11 Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: Physiology, pathophysiology and pharmacology.  Pharmacol Rev. 1991;  43 109-42
• 12 Furchgott R F. Role of the endothelium in responses of vascular smooth muscle.  Circ Res. 1983;  53 557-73
• 13 Vanhoutte P M, Boulanger C M, Mombouli J V. Endothelium-derived relaxing factors and converting enzyme inhibition.  Am J Cardiol. 1995;  76 3E-12E
• 14 Brunning T A, Hendricks M GC, Chang P C, Kuypers E AP, Van Zwieten P A. In vivo characterization of vasodilating muscarinic receptors in humans.  Circ Res. 1994;  74 912-9
• 15 Moncada S, Higgs E A. The L-arginine-nitric oxide pathway.  N Engl J Med. 1993;  29 2002-12
• 16 Nelson M T, Patlak J B, Worley J F, Standen N B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.  Am J Physiol (1 Pt 1). 1990;  259 C3-C18
• 17 Karaki H, Weiss G B. Calcium release in smooth muscle.  Life Sci. 1988;  42 111-22
• 18 Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won K J, Sato K. Calcium movements, distribution, and functions in smooth muscle.  Pharmacol Rev. 1997;  49 (suppl 2) 157-230
• 19 Bootman M D, Berridge M J. The elemental principles of calcium signaling.  Cell. 1995;  83 (suppl 5) 675-8